öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÁÖ»Ô
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º109

ËùÊôԺУ£ºÓÒ½­Ãñ×åҽѧԺ
ËùÊôԺϵ£º
Ö°³Æ£ºÖ÷ÈÎҽʦ
µ¼Ê¦ÀàÐÍ£º
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º
Ñо¿ÁìÓò£º 1.·Î°©µÄ»ù´¡ÓëÁÙ´²Ñо¿2.ÐÄÔ಻ͣÌøÐÄÄÚÖ±ÊÓÊÖÊõµÄ»ù´¡ºÍÁÙ´²Ñо¿
Ñо¿ÁìÓò£º 1.·Î°©µÄ»ù´¡ÓëÁÙ´²Ñо¿2.ÐÄÔ಻ͣÌøÐÄÄÚÖ±ÊÓÊÖÊõµÄ»ù´¡ºÍÁÙ´²Ñо¿ [ÊÕÆð]




ͨѶ·½Ê½ :
µç×ÓÓʼþ£ºLinhui33622@sina.com


¸öÈ˼òÊö :
¹¤×÷¾­Àú£º1983.1-1985.8¹ãÎ÷ҽѧԺµÚÒ»¸½ÊôÒ½ÔºÍâ¿Æ¹¤×÷£» 1985.9-1987.7¹ãÎ÷ҽѧԺÐØÐÄѪ¹ÜÍâ¿Æ˶ʿÑо¿Éú£¬»ñҽѧ˶ʿѧλ 1987.7-1992.3¹ãÎ÷ҽѧԺµÚÒ»¸½ÊôÒ½ÔºÐØÐÄѪ¹ÜÍâ¿Æ¹¤×÷ 1992.4-1994.3ÈÕ±¾¹úÁ¢Ãû¹ÅÎÝ´óѧҽѧ²¿¸½ÊôÒ½ÔºÐز¿Íâ¿ÆÑÐÐÞ 1994.4-2001.5¹ãÎ÷Ò½¿Æ´óѧµÚÒ»¸½ÊôÒ½ÔºÐØÐÄѪ¹ÜÍâ¿Æ¹¤×÷£¬ÀúÈιãÎ÷Ò½¿Æ´óѧÐÄѪ¹Ü¼²²¡Ñо¿Ëù¸±Ëù³¤£¬´óÍâ¿Æ¸±Ö÷ÈΣ¬ÐØÐÄÍâ¿ÆÖ÷ÈΣ¬¸±Ö÷ÈÎҽʦ£¬Ö÷ÈÎҽʦ£¬½ÌÊÚ 1997.7-2000.6ºþ±±Ò½¿Æ´óѧµÚÒ»¸½ÊôÒ½ÔºÐØÐÄѪ¹ÜÍâ¿Æ²©Ê¿Ñо¿Éú£¬»ñҽѧ²©Ê¿Ñ§Î» 1998.09 ÃÀ¹úŦԼҽѧԺWestchester Ò½ÁÆÖÐÐĹÚÂöÍâ¿Æ¼¼ÊõÅàѵ 2001.6ÖÁ½ñ ¹ãÎ÷׳×å×ÔÖÎÇøÈËÃñÒ½Ôº¹¤×÷£¬Èγ£Îñ¸±Ôº³¤¼æ¹ãÎ÷½ô¼±¾ÈÔ®ÁÙ´²Ò½ÁÆÖÐÐÄÖ÷ÈΡ¢ÐØÐÄѪ¹ÜÍâ¿ÆÖ÷ÈΡ¢±ÇÑÊ°©Ñо¿ËùËù³¤¡¢ÁÙ´²Ö×ÁöÖÎÁÆÖÐÐÄÖ÷ÈÎ
Éç»áÖ÷Òª¼æÖ°£ºÖйúҽʦЭ»áÀíÊ¡¢ÖйúҽʦЭ»áÐÄѪ¹ÜÍâ¿Æҽʦ·Ö»á³£Î¯£¬ÖйúҽʦЭ»áÐØÍâ¿Æҽʦ·Ö»áίԱ£¬Öйú¾ÈԮҽѧ»á³£Î¯£¬ÖлªÒ½Ñ§»áÐØÐÄѪ¹ÜÍâ¿Æ·Ö»áίԱ£»¹ãÎ÷ҽʦЭ»á³£Î¯£¬¹ãÎ÷ҽѧ»áÐØÐÄѪ¹ÜÍâ¿Æ·Ö»áÖ÷ÈÎίԱ£¬Æ÷¹ÙÒÆÖ²·Ö»á¸±Ö÷ί£¬¹ãÎ÷¿¹°©Ð­»á·Î°©öλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á¸±Ö÷ί

¿ÆÑй¤×÷ :
1.CCL25/CCR9ÉúÎïÖá´Ù½ø·ÇСϸ°û·Î°©ÁܰͽáתÒƵĻúÖÆÑо¿ ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÏîÄ¿¸ºÔðÈËÏîÄ¿±àºÅ£º** 2.·ÎÏÙ°©Êõºó pN2»¼Õßͬ²½·Å»¯ÁÆÓëÐò¹á·Å»¯ÁƵÄÁÙ´²¶ÔÕÕÑо¿ ¹ãÎ÷¿ÆѧÑо¿Óë¼¼Êõ¿ª·¢¼Æ»®ÏîÄ¿ÏîÄ¿¸ºÔðÈË ÏîÄ¿±àºÅ£º¹ð¿Æ¹¥**-1-19
»ñµÃµÄÖ÷Òª¿ÆÑн±Ï(2012Äê1ÔÂ1ÈÕ-ÖÁ½ñ) 1.ÐÄÔàÒÆֲʵÑéÓëÁÙ´²Ó¦ÓÃÑо¿ 2013 ¹ãÎ÷¿Æ¼¼½ø²½½±¶þµÈ½± £¨ÅÅÃûµÚ1£© 2.ÐÄÔ಻ͣÌøÂýÐÔÐÄ·¿²ü¶¯Íâ¿ÆÖÎÁƵÄÁÙ´²Ñо¿ 2013 ¹ãÎ÷Ò½Ò©ÎÀÉúÊÊÒ˼¼ÊõÍƹ㽱ÈýµÈ½± £¨ÅÅÃûµÚ2£© 3. BRCA1¡¢DNA-PKcsµ°°×±í´ï¶Ô±ÇÑÊ°©µÄÔ¤ºó¼ÛÖµ 2014 ¹ãÎ÷Ò½Ò©ÎÀÉúÊÊÒ˼¼ÊõÍƹ㽱¶þµÈ½±(ÅÅÃûµÚ2)
¸öÈËÈÙÓþ£º(2012Äê1ÔÂ1ÈÕ-ÖÁ½ñ) 1.2012Äê12ÔÂÈÙ»ñÈËÁ¦×ÊÔ´Éç»á±£Õϲ¿¡¢ÎÀÉú²¿¡¢¹ú¼ÒÖÐÒ½Ò©¹ÜÀí¾ÖÁªºÏÊÚÓè¡°È«¹úÎÀÉúϵͳÏȽø¹¤×÷Õß¡± 2.2015Äê12ÔÂÈÙ»ñ¹ãÎ÷ÎÀÉúÓ¦¼±¹¤×÷¹±Ï×Í»³ö¸öÈË

Ñо¿ÉúÅàÑø ¹²ÕÐÉú²©Ê¿Ñо¿Éú5ÈË£¬Ë¶Ê¿Ñо¿Éú10ÈË£¬ÒѱÏÒµ14¸ö,(º¬²©Ê¿Ñо¿Éú5¸ö)
½üÆÚ´ú±íÐÔÂÛÎļ°³É¹û ½üÄê·¢±í´ú±íÐÔÂÛÎÄ£º(2012Äê1ÔÂ1ÈÕ-ÖÁ½ñ) 1.Impact of the number of resected lymph nodes on survival after preoperative radiotherapy for esophageal cancer Oncotarget. 2016, 7(16): 22497-22507. SCI£¬Í¨Ñ¶×÷Õß 2.Surgical Treatment of Dextroversion, Isolated Persistent Left Superior Vena Cava Draining Into the Left Atrium? J Card Surg. 2015, 30(10): 767-770.? SCI£¬Í¨Ñ¶×÷Õß 3.CCR9-CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K/Akt pathway Med Oncol. 2015, 32(3): 66. SCI£¬Í¨Ñ¶×÷Õß 4.Expression of CC chemokine receptor 9 predicts poor prognosis in patients with lung adenocarcinoma?? Diagn Pathol. 2015, 10: 101. SCI£¬Í¨Ñ¶×÷Õß 5.Dosimetric study of a respiratory gating technique based on four-dimensional computed tomography in non-small-cell lung cancer J Radiat Res. 2014, 55(3): 583-588.?? SCI£¬µÚÒ»×÷Õß 6.CD59 is overexpressed in human lung cancer and regulates apoptosis of human lung cancer cells Int J Oncol. 2013, 43(3): 850-858.?? SCI£¬Í¨Ñ¶×÷Õß 7.Keeping donor hearts in completely beating status with normothermic blood perfusion for transplants?? Ann Thorac Surg. 2013, 95(6): 2028-2034. SCI£¬Í¨Ñ¶×÷Õß 8.·ÇСϸ°û·Î°©×éÖ¯CCR9ºÍSurvivin¼°Bcl-2±í´ïÏà¹ØÐÔÑо¿ ÖлªÖ×Áö·ÀÖÎÔÓÖ¾,2013,16:1232-1235. ÖÐÎĺËÐÄ£¬Í¨Ñ¶×÷Õß 9.119Àý·ÇСϸ°û·Î°©ÖÐCCR9µÄ±í´ï¼°ÆäÔ¤ºó·ÖÎö? ÁÙ´²ÓëʵÑ鲡ÀíѧÔÓÖ¾£¬2015£¬31£¨7£©£º764-768 ÖÐÎĺËÐÄ£¬Í¨Ñ¶×÷Õß 10.ʳ¹ÜÁÛ°©ÖÐE-cadherinµ°°×±í´ï¼°ÆäÁÙ´²ÒâÒåµÄMeta·ÖÎö ¹ãÎ÷ҽѧ 2013:304-8. ¿Æ¼¼ºËÐÄ£¬Í¨Ñ¶×÷Õß ½üÄê³ö°æÖø×÷Óë½Ì²Ä£º(2012Äê1ÔÂ1ÈÕ-ÖÁ½ñ) 1.¡¶ÌåÍâÑ­»·ÐÄÔ಻ͣÌøÊÖÊõ¡·Ö÷±à¡¢Ö÷É󣬹ãÎ÷¿Æѧ¼¼Êõ³ö°æÉ磬2016Äê9Ô 2.¡¶¡°»¥ÁªÍø+Ò½Áƽ¡¿µ¡±Ê±´úÒ½Ôº¹ÜÀí´´ÐÂÓë·¢Õ¹¡·¶ÀÖø£¬Ç廪´óѧ³ö°æÉ磬2016Äê5ÔÂ

½ÌÓý±³¾° :
1982Äê±ÏÒµÓÚ¹ãÎ÷ҽѧԺ£¬»ñҽѧѧʿѧλ£»1987Äê±ÏÒµÓÚ¹ãÎ÷ҽѧԺ£¬»ñҽѧ˶ʿѧλ £»2000Äê±ÏÒµÓÚºþ±±Ò½¿Æ´óѧ£¬»ñҽѧ²©Ê¿Ñ§Î»